Clinquest Group Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
46
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
- Investments
-
1
Clinquest Group General Information
Description
Provider of clinical research services. The company specializes in consulting services for drug discovery and development, implementation, post-approval and compound partnering programs for pharmaceutical, biotechnology, biomedical device and medical data industries. It provides clinical research, data management, biostatistics, medical information and pharmacovigilance services to the pharmaceutical and biotech industries.
Contact Information
Website
www.clinquest.comCorporate Office
- Science Park 406
- 1098 XH Amsterdam
- Netherlands
Corporate Office
- Science Park 406
- 1098 XH Amsterdam
- Netherlands
Clinquest Group Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Clinquest Group Patents
Clinquest Group Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
DE-69941431-D1 | A compound which inhibits the binding of a protein to mouse cells, the use of the compound for the preparation of a medicament, and a pharmaceutical composition | Inactive | 09-Jul-1998 | ||
ES-2333493-T3 | Composite capable of inhibiting the link of a protein with the mastocits, employment of such compound in the preparation of a medicinal product, pharmaceutical composition, procedure for diagnosing a disease and selection procedure. | Inactive | 09-Jul-1998 | ||
CA-2332561-A1 | Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection | Active | 09-Jul-1998 | ||
CA-2332561-C | Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection | Inactive | 09-Jul-1998 | ||
EP-1093462-B1 | Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection | Inactive | 09-Jul-1998 | C07K14/47 |
Clinquest Group Signals
Clinquest Group Investments (1)
Clinquest Group’s most recent deal was a Early Stage VC with Enceladus Pharmaceuticals. The deal was made on 09-Jul-2007.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Enceladus Pharmaceuticals | 09-Jul-2007 | Early Stage VC | Drug Discovery |
Clinquest Group Exits (1)
Clinquest Group’s most recent exit was on 09-Jul-2007 from Enceladus Pharmaceuticals. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Enceladus Pharmaceuticals | 09-Jul-2007 | Completed |
|
Clinquest Group FAQs
-
When was Clinquest Group founded?
Clinquest Group was founded in 1998.
-
Where is Clinquest Group headquartered?
Clinquest Group is headquartered in Amsterdam, Netherlands.
-
What is the size of Clinquest Group?
Clinquest Group has 46 total employees.
-
What industry is Clinquest Group in?
Clinquest Group’s primary industry is Discovery Tools (Healthcare).
-
Is Clinquest Group a private or public company?
Clinquest Group is a Private company.
-
What is Clinquest Group’s current revenue?
The current revenue for Clinquest Group is
. -
When was Clinquest Group acquired?
Clinquest Group was acquired on 02-Dec-2015.
-
Who acquired Clinquest Group?
Clinquest Group was acquired by Accelovance.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »